Guardant Health launches Shield Multi-Cancer Detection Test in APAC market 

Guardant Health, Inc., a leading precision oncology company, has announced the launch of the Shield™ multi-cancer ...

March 17, 2026 | Tuesday | News
China approves Zydus' drug for renal anaemia treatment

India-based Zydus Lifesciences has announced that its innovative drug Desidustat tablets, licensed to the subsidiary of ...

March 16, 2026 | Monday | News
LabConnect expands global central laboratory infrastructure with China facility

LabConnect, a leading provider of technology-driven central laboratory services and functional service provider sol...

March 13, 2026 | Friday | News
Codex Genetics, C2N to launch Alzheimer's blood test in Hong Kong

Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, has announced a strategic collaborat...

March 11, 2026 | Wednesday | News
China's CK Life Sciences establishes Sequencio Therapeutics for cancer vaccines development

Hong Kong-based CK Life Sciences has announced the establishment of Sequencio Therapeutics, a wholly-owned subsidiary de...

March 12, 2026 | Thursday | News
Tsingke Biotech and iGeneTech partner to lead synthetic biology advancements in China

Beijing Tsingke Biotech and iGeneTech Bioscience have announced a strategic partnership aimed at advancing the fiel...

March 10, 2026 | Tuesday | News
China approves Sciwind Biosciences' Ecnoglutide injection for chronic weight management

Hangzhou Sciwind Biosciences has announced that China's National Medical Products Administration (NMPA) has approved Ecn...

March 7, 2026 | Saturday | News
MGI Tech aquires STOmics and CycloneSEQ to advance spatial biology and nanopore sequencing technologies

MGI Tech Co., Ltd. , a company dedicated to developing core tools and technologies that drive innovation in the life sci...

March 4, 2026 | Wednesday | News
Singapore & Hong Kong deepen partnership to advance precision eye health

The Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and t...

March 4, 2026 | Wednesday | News
China's WuXi XDC partners with Earendil Labs for Payload-Linker Technology Platform

China-based WuXi XDC Cayman Inc. (WuXi XDC), a leading global CRDMO (Contract Research, Development, and Manufacturing O...

March 2, 2026 | Monday | News
China's Frontier Biotech inks $963 M deal with GSK for small interfering RNA therapeutics

China-based Frontier Biotechnologies Inc. has entered into an exclusive licensing agreement with GSK, a global biop...

February 27, 2026 | Friday | News
Hong Kong, Sweden collaboration to advance mesenchymal stromal cell therapy for knee osteoarthritis

The InnoHK Centre for Neuromusculoskeletal Restorative Medicine (CNRM), established by The Chinese University of Hong Ko...

February 26, 2026 | Thursday | News
Junshi Biosciences enters strategic collaboration with Antengene to evaluate combination therapy in China

Shanghai Junshi Biosciences Co., Ltd, a leading innovation-driven biopharmaceutical company dedicated to the discovery, ...

February 25, 2026 | Wednesday | News
Sciwind Biosciences partners with Pfizer China to commercialise Biased GLP-1 in China in $495 M deal

Hangzhou Sciwind Biosciences has announced a strategic commercialisation collaboration with Pfizer China for Ecnoglutide...

February 24, 2026 | Tuesday | News
QuidelOrtho enters strategic supply agreement to expand global immunoassay portfolio

QuidelOrtho has entered a long-term strategic supply agreement with China's Lifotronic Technology, to expand QuidelOrtho...

February 16, 2026 | Monday | News
CARsgen invests RMB 370 M to expand CAR-T commercial manufacturing base in Shanghai

CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that through its in...

February 13, 2026 | Friday | News
Madrigal expands MASH pipeline with siRNA therapies in $4.4 B deal

Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabo...

February 12, 2026 | Thursday | News
Innovent inks $8.5 B deal with Eli Lilly for oncology and immunology based medicines

China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to a...

February 10, 2026 | Tuesday | News
First Promega companion diagnostic receives China's NMPA approval

The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Dete...

February 5, 2026 | Thursday | News
Hong Kong to nurture dietetic professionals with new academic programme

In response to the growing demand amid Hong Kong’s rapidly ageing population for healthcare professionals such as ...

February 4, 2026 | Wednesday | News
Frontage Labs strengthens early phase clinical capabilities across US and China

Frontage Laboratories, Inc., a global Contract Research, Development and Manufacturing Organization (CRDMO), has announc...

February 2, 2026 | Monday | News
AstraZeneca inks billion-dollar deal with China's CSPC Pharma to expand weight management portfolio

AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...

February 3, 2026 | Tuesday | News
AstraZeneca plans $15 B investment in China to expand medicines manufacturing and R&D

AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...

January 30, 2026 | Friday | News
WuXi Biologics and HanchorBio advances next-generation Bi- and Multi-functional fusion protein pipeline

WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...

January 29, 2026 | Thursday | News
Boehringer Ingelheim, Simcere Pharma collaborate on €1,058 M IBD antibody deal

China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...

January 28, 2026 | Wednesday | News